LSP acquired by EQT and rebranded EQT Life Sciences is one of Europe’s largest and most experienced healthcare investors, targeting innovative life sciences and health care companies.
| Website | https://eqtgroup.com/lifesciences |
| Revenue | $2.3 billion |
| Employees | 381 (381 on RocketReach) |
| Founded | 1987 |
| Industry | Venture Capital and Private Equity Principals |
| Keywords | Healthcare Investment, Life Sciences Investment, Biotechnology Investment, Pharmaceutical Investment, Health Tech Investment, Private Equity Healthcare, Innovative Healthcare, Healthcare Portfolio, Biotech Portfolio, Pharmaceutical Portfolio, Growth Equity Healthcare, Venture Capital Healthcare, Healthcare Acquisitions, Pharmaceutical Acquisitions |
| Competitors | Morgan Stanley, TPG, Advent International, RA Capital Management, L.P., SV Health Investors, Frazier Healthcare Partners, New Enterprise Associates (NEA), OrbiMed, Canaan, HealthQuest Capital +38 more (view full list) |
Looking for a particular LSP employee's phone or email?
The LSP annual revenue was $2.3 billion in 2026.
Merijn Klaassen is the CFO and COO of LSP.
381 people are employed at LSP.